HONG KONG, Nov. 5, 2018 /PRNewswire/ — Ms. Kimberly Nearing, the Managing Director, Head of Life Sciences at Cedrus Investments (“Cedrus”), was invited to speak on a panel at the Life Sciences Summit held on 25th October at the Time Warner Center in New York City.
The Life Sciences Summit is an investor and business development conference focusing on emerging companies and academic innovators. The objective of the event is to connect biotech innovators with potential financiers and industry partners they will need to move new discoveries into clinical development. Participants included: a Partner, Third Rock Ventures; Senior Director Business Development, AstraZeneca; Executive Director, Merck; a MD from the Memorial Sloan-Kettering Cancer Center; Oncology External Innovation, Eli Lilly; a Partner, Venrock; Senior Advisor, Aisling Capital; Managing Director, Evercore; a Partner, Canaan Partners; and Principal, Merck Ventures.
Ms. Nearing participated in the Cross-border Investment and Partnering Opportunities panel. Ms. Nearing’s fellow panelist included: Dr. Michael Baran, PhD, MBA, Principal, Pfizer Ventures and Executive Director, External Science & Innovation, Oncology Research, Worldwide R&D, Pfizer, Inc., Dr. Xiaodong (Eric) Wu, International Business Development Manager, Qilu Pharmaceutical, and Dr. Yan Zhang, PhD, Investment Director, Cowin Capital. The panel engaged in lively discussion about the following: 1) What Chinese investors and companies are looking for? 2) How do Chinese investors negotiate for value of early-stage life sciences companies? 3) What are the key challenges in conducting cross-border deals/partner search and how to avoid them?
Ms. Diane Fabel, Director of Operations, Center for Biotechnology & Long Island Bioscience Hub, Executive Director, Life Sciences Summit, said, “As Head of Life Sciences at Cedrus Investments, Ms. Nearing brings a wealth of expertise and insight into US/China cross-border investments and strategic partnerships. Her more than 20 years of experience in the life sciences industry, coupled with extensive transaction based experience in raising capital and fostering strategic alliances at the highest levels, contributed significant value to the plenary discussion and our Life Sciences Summit delegates.”
About Cedrus Investments
Cedrus Investments is a global boutique investment firm headquartered in Hong Kong, specializing in Asset Management and Financial Advisory Services. Cedrus has extensive experience and a global network in the life sciences industry together with cross-border transactions in geographies including China, Australia, Asia, U.S., and Europe.
Cedrus Investments Ltd.